Dova Pharmaceuticals, Inc.

Home » Dova Pharmaceuticals, Inc.

Secondary

Dova Pharmaceuticals, Inc.

Dova is a pharmaceutical company focused on acquiring, developing, and commercializing drug candidates for rare diseases where there is a high unmet need, with an initial focus on addressing thrombocytopenia.

Symbol

DOVA

Last Closing Price
$32.88

Shares
2,500,000

Effective Date
February 23, 2018

Underwriters
J.P. Morgan, Jefferies, Evercore ISI

To view the prospectus for Dova Pharmaceuticals, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253